Synthesis and screening of a library of Lewis


Journal

Nature communications
ISSN: 2041-1723
Titre abrégé: Nat Commun
Pays: England
ID NLM: 101528555

Informations de publication

Date de publication:
13 Sep 2024
Historique:
received: 22 05 2024
accepted: 30 07 2024
medline: 14 9 2024
pubmed: 14 9 2024
entrez: 13 9 2024
Statut: epublish

Résumé

Glycan-mediated interactions play a crucial role in biology and medicine, influencing signalling, immune responses, and disease pathogenesis. However, the use of glycans in biosensing and diagnostics is limited by cross-reactivity, as certain glycan motifs can be recognised by multiple biologically distinct protein receptors. To address this specificity challenge, we report the enzymatic synthesis of a 150-member library of site-specifically fluorinated Lewis

Identifiants

pubmed: 39271664
doi: 10.1038/s41467-024-51081-7
pii: 10.1038/s41467-024-51081-7
doi:

Substances chimiques

Polysaccharides 0
Lewis X Antigen 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

7925

Subventions

Organisme : RCUK | Biotechnology and Biological Sciences Research Council (BBSRC)
ID : BB/M02878X/1
Organisme : RCUK | Biotechnology and Biological Sciences Research Council (BBSRC)
ID : BB/M028852/1
Organisme : RCUK | Biotechnology and Biological Sciences Research Council (BBSRC)
ID : BB/M028941/1
Organisme : RCUK | Biotechnology and Biological Sciences Research Council (BBSRC)
ID : BB/M02847X/1
Organisme : RCUK | Biotechnology and Biological Sciences Research Council (BBSRC)
ID : BB/M028976/1
Organisme : RCUK | Biotechnology and Biological Sciences Research Council (BBSRC)
ID : BB/M028747/1
Organisme : RCUK | Biotechnology and Biological Sciences Research Council (BBSRC)
ID : BB/M028836
Organisme : RCUK | Biotechnology and Biological Sciences Research Council (BBSRC)
ID : BB/M011151/1
Organisme : RCUK | Biotechnology and Biological Sciences Research Council (BBSRC)
ID : BB/V50953X/1
Organisme : Wellcome Trust (Wellcome)
ID : WT099197/Z/12/Z
Organisme : Wellcome Trust (Wellcome)
ID : 108430/Z/15/Z
Organisme : Wellcome Trust (Wellcome)
ID : 218304/Z/19/Z
Organisme : Wellcome Trust (Wellcome)
ID : 102576/Z/13/Z
Organisme : EC | EU Framework Programme for Research and Innovation H2020 | H2020 Priority Excellent Science | H2020 European Research Council (H2020 Excellent Science - European Research Council)
ID : ERC-COG: 648239
Organisme : EC | EU Framework Programme for Research and Innovation H2020 | H2020 Priority Excellent Science | H2020 European Research Council (H2020 Excellent Science - European Research Council)
ID : ProgrES-ERC-2017-ADG
Organisme : RCUK | Engineering and Physical Sciences Research Council (EPSRC)
ID : DTA1799721

Informations de copyright

© 2024. The Author(s).

Références

Varki, A. Biological roles of glycans. Glycobiology 27, 3–49 (2017).
pubmed: 27558841 doi: 10.1093/glycob/cww086
Solis, D. et al. A guide into glycosciences: how chemistry, biochemistry and biology cooperate to crack the sugar code. Biochim. Biophys. Acta 1850, 186–235 (2015).
pubmed: 24685397 doi: 10.1016/j.bbagen.2014.03.016
Larkin, M. et al. Spectrum of sialylated and nonsialylated fuco-oligosaccharides bound by the endothelial-leukocyte adhesion molecule E-selectin. Dependence of the carbohydrate binding activity on E-selectin density. J. Biol. Chem. 267, 13661–13668 (1992).
pubmed: 1377689 doi: 10.1016/S0021-9258(18)42264-8
Richards, S.-J. & Gibson, M. I. Toward glycomaterials with selectivity as well as affinity. JACS Au 1, 2089–2099 (2021).
pubmed: 34984416 pmcid: 8717392 doi: 10.1021/jacsau.1c00352
Wang, Z. et al. A general strategy for the chemoenzymatic synthesis of asymmetrically branched N-glycans. Science 341, 379–383 (2013).
pubmed: 23888036 doi: 10.1126/science.1236231
Dubacheva, G. V., Curk, T. & Richter, R. P. Determinants of superselectivity─practical concepts for application in biology and medicine. Acc. Chem. Res. 56, 729–739 (2023).
pubmed: 36916901 pmcid: 10077582 doi: 10.1021/acs.accounts.2c00672
Shinya, K. et al. Influenza virus receptors in the human airway. Nature 440, 435–436 (2006).
pubmed: 16554799 doi: 10.1038/440435a
Baker, A. N. et al. Glycan-based flow-through device for the detection of SARS-COV-2. ACS Sens. 6, 3696–3705 (2021).
pubmed: 34634204 pmcid: 8525701 doi: 10.1021/acssensors.1c01470
Kim, S. H. et al. GlycoGrip: cell surface-inspired universal sensor for betacoronaviruses. ACS Cent. Sci. 8, 22–42 (2022).
pubmed: 35106370 doi: 10.1021/acscentsci.1c01080
Glaudemans, C. P. J. Mapping of subsites of monoclonal, anti-carbohydrate antibodies using deoxy and deoxyfluoro sugars. Chem. Rev. 91, 25–33 (1991).
doi: 10.1021/cr00001a002
Maximilian, R. & Anja, H.-R. Antibody recognition of fluorinated haptens and antigens. Curr. Top. Med. Chem. 14, 840–854 (2014).
doi: 10.2174/1568026614666140202203811
Linclau, B. et al. Fluorinated carbohydrates as chemical probes for molecular recognition studies. current status and perspectives. Chem. Soc. Rev. 49, 3863–3888 (2020).
pubmed: 32520059 doi: 10.1039/C9CS00099B
Dalvit, C. & Vulpetti, A. Weak intermolecular hydrogen bonds with fluorine: detection and implications for enzymatic/chemical reactions, chemical properties, and ligand/protein fluorine NMR screening. Chem. Eur. J. 22, 7592–7601 (2016).
pubmed: 27112430 doi: 10.1002/chem.201600446
Paquin, J.-F., Champagne, P. & Desroches, J. Organic fluorine as a hydrogen-bond acceptor: recent examples and applications. Synthesis 47, 306–322 (2015).
doi: 10.1055/s-0034-1379537
Santana, A. G. et al. A dynamic combinatorial approach for the analysis of weak carbohydrate/aromatic complexes: dissecting facial selectivity in CH/pi stacking interactions. J. Am. Chem. Soc. 135, 3347–3350 (2013).
pubmed: 23418701 doi: 10.1021/ja3120218
Calle, L. P. et al. Monitoring glycan–protein interactions by NMR spectroscopic analysis: a simple chemical tag that mimics natural CH–π interactions. Chem. Eur. J. 21, 11408–11416 (2015).
pubmed: 26177718 doi: 10.1002/chem.201501248
Unione, L. et al. Fluoroacetamide Moieties as NMR Probes for molecular recognition of GlcNAc-containing sugars: Modulation of the CH-pi stacking interactions by different fluorination patterns. Chem. Eur. J. 23, 3957–3965 (2017).
pubmed: 28124793 doi: 10.1002/chem.201605573
Linclau, B. et al. Investigating the Influence of (Deoxy)fluorination on the Lipophilicity of Non-UV-Active Fluorinated Alkanols and Carbohydrates by a new log P determination method. Angew. Chem. Int. Ed. Engl. 55, 674–678 (2016).
pubmed: 26592706 doi: 10.1002/anie.201509460
St-Gelais, J., Côté, É., Lainé, D., Johnson, P. A. & Giguère, D. Addressing the structural complexity of fluorinated glucose analogues: insight into lipophilicities and solvation effects. Chem. Eur. J. 26, 13499–13506 (2020).
pubmed: 32652740 doi: 10.1002/chem.202002825
Kurfirt, M. et al. Selectively deoxyfluorinated N-acetyllactosamine analogues as 19 F NMR probes to study carbohydrate-galectin interactions. Chem. Eur. J. 27, 13040–13051 (2021).
pubmed: 34216419 doi: 10.1002/chem.202101752
Paulini, R., Müller, K. & Diederich, F. Orthogonal multipolar interactions in structural chemistry and biology. Angew. Chem. Int. Ed. 44, 1788–1805 (2005).
doi: 10.1002/anie.200462213
Dohi, H. et al. Stereoselective glycal fluorophosphorylation: synthesis of ADP-2-fluoroheptose, an inhibitor of the LPS biosynthesis. Chem. Eur. J. 14, 9530–9539 (2008).
pubmed: 18833547 doi: 10.1002/chem.200801279
Yu, Y. & Delbianco, M. Conformational studies of oligosaccharides. Chem. Eur. J. 26, 9814–9825 (2020).
pubmed: 32329095 doi: 10.1002/chem.202001370
Anggara, K. et al. Identifying the origin of local flexibility in a carbohydrate polymer. Proc. Natl. Acad. Sci. USA 118, e2102168118 (2021).
pubmed: 34074784 pmcid: 8201824 doi: 10.1073/pnas.2102168118
Richards, S.-J. et al. Introducing affinity and selectivity into galectin-targeting nanoparticles with fluorinated glycan ligands. Chem. Sci. 12, 905–910 (2021).
doi: 10.1039/D0SC05360K
Gooi, H. C. et al. Stage-specific embryonic antigen involves alpha 1 goes to 3 fucosylated type 2 blood group chains. Nature 292, 156–158 (1981).
pubmed: 6165896 doi: 10.1038/292156a0
Streit, A. et al. The lex carbohydrate sequence is recognized by antibody to L5, a functional antigen in early neural development. J. Neurochem. 66, 834–844 (1996).
pubmed: 8592159 doi: 10.1046/j.1471-4159.1996.66020834.x
Feizi, T. Demonstration by monoclonal antibodies that carbohydrate structures of glycoproteins and glycolipids are onco-developmental antigens. Nature 314, 53–57 (1985).
pubmed: 2579340 doi: 10.1038/314053a0
Hakomori, S.-i. in Advances in Cancer Research, 52. (eds. G. F. Vande Woude & G. Klein) 257–331 (Academic Press, 1989).
Watkins, W. M. Biochemistry and Genetics of the ABO, Lewis, and P blood group systems. Adv. Hum. Genet 10, 1–136, 379-185 (1980).
pubmed: 6156588
Ayechu-Muruzabal, V. et al. Diversity of human milk oligosaccharides and effects on early life immune development. Front Pediatr. 6, 239 (2018).
pubmed: 30250836 pmcid: 6140589 doi: 10.3389/fped.2018.00239
Aspinall, G. O., Monteiro, M. A., Pang, H., Walsh, E. J. & Moran, A. P. Lipopolysaccharide of the helicobacter pylori type strain NCTC 11637 (ATCC 43504): structure of the O antigen chain and core oligosaccharide regions. Biochemistry 35, 2489–2497 (1996).
pubmed: 8652593 doi: 10.1021/bi951852s
Hokke, C. H. & Deelder, A. M. Schistosome glycoconjugates in host-parasite interplay. Glycoconj. J. 18, 573–587 (2001).
pubmed: 12376724 doi: 10.1023/A:1020634602161
Palma, A. S., Feizi, T., Childs, R. A., Chai, W. & Liu, Y. The neoglycolipid (NGL)-based oligosaccharide microarray system poised to decipher the meta-glycome. Curr. Opin. Chem. Biol. 18, 87–94 (2014).
pubmed: 24508828 pmcid: 4105633 doi: 10.1016/j.cbpa.2014.01.007
Huang, K. et al. Biochemical characterisation of an α1,4 galactosyltransferase from Neisseria weaveri for the synthesis of α1,4-linked galactosides. Org. Biomol. Chem. 18, 3142–3148 (2020).
pubmed: 32255449 doi: 10.1039/D0OB00407C
Chen, M. et al. Wide sugar substrate specificity of galactokinase from Streptococcus pneumoniae TIGR4. Carbohydr. Res. 346, 2421–2425 (2011).
pubmed: 21903203 doi: 10.1016/j.carres.2011.08.014
Saito, S., Ozutsumi, M. & Kurahashi, K. Galactose l-phosphate uridylyltransferase of escherichia coli: II. Further purification and characterization. J. Biol. Chem. 242, 2362–2368 (1967).
pubmed: 5338129 doi: 10.1016/S0021-9258(18)95970-3
Muthana, M. M. et al. Efficient one-pot multienzyme synthesis of UDP-sugars using a promiscuous UDP-sugar pyrophosphorylase from Bifidobacterium longum (BLUSP). Chem. Commun. 48, 2728–2730 (2012).
doi: 10.1039/c2cc17577k
Ghirardello, M., Zhang, Y.-Y., Voglmeir, J. & Galan, M. C. Recent applications of ionic liquid-based tags in glycoscience. Carbohydr. Res. 520, 108643 (2022).
pubmed: 35977445 doi: 10.1016/j.carres.2022.108643
Galan, M. C., Anh Tuan, T., Bromfield, K., Rabbani, S. & Ernst, B. Ionic-liquid-based MS probes for the chemo-enzymatic synthesis of oligosaccharides. Org. Biomol. Chem. 10, 7091–7097 (2012).
pubmed: 22875034 doi: 10.1039/c2ob25855b
Sittel, I. & Galan, M. C. Chemo-enzymatic synthesis of imidazolium-tagged sialyllactosamine probes. Bioorg. Med. Chem. Lett. 25, 4329–4332 (2015).
pubmed: 26318990 doi: 10.1016/j.bmcl.2015.07.049
Ramakrishnan, B., Ramasamy, V. & Qasba, P. K. Structural snapshots of β-1,4-galactosyltransferase-I along the kinetic pathway. J. Mol. Biol. 357, 1619–1633 (2006).
pubmed: 16497331 doi: 10.1016/j.jmb.2006.01.088
Ge, Z., Chan, N. W. C., Palcic, M. M. & Taylor, D. E. Cloning and heterologous expression of an α1,3-fucosyltransferase gene from the gastric PathogenHelicobacter pylori. J. Biol. Chem. 272, 21357–21363 (1997).
pubmed: 9261149 doi: 10.1074/jbc.272.34.21357
Wang, W. et al. Chemoenzymatic synthesis of GDP-L-fucose and the Lewis X glycan derivatives. Proc. Natl. Acad. Sci. USA 106, 16096–16101 (2009).
pubmed: 19805264 pmcid: 2752511 doi: 10.1073/pnas.0908248106
Sun, H.-Y. et al. Structure and Mechanism of Helicobacter pylori Fucosyltransferase: A Basis for Lipopolysaccharide Variation and Inhibitor Design. J. Biol. Chem. 282, 9973–9982 (2007).
pubmed: 17251184 doi: 10.1074/jbc.M610285200
Zierke, M. et al. Stabilization of branched oligosaccharides: Lewisx benefits from a nonconventional C–H···O hydrogen bond. J. Am. Chem. Soc. 135, 13464–13472 (2013).
pubmed: 24001318 doi: 10.1021/ja4054702
Imberty, A. & Pérez, S. Structure, conformation, and dynamics of bioactive oligosaccharides: theoretical approaches and experimental validations. Chem. Rev. 100, 4567–4588 (2000).
pubmed: 11749358 doi: 10.1021/cr990343j
Feizi, T. & Chai, W. Oligosaccharide microarrays to decipher the glyco code. Nat. Rev. Mol. Cell Biol. 5, 582–588 (2004).
pubmed: 15232576 doi: 10.1038/nrm1428
Hu, Y. & Schomaker, J. M. Recent developments and strategies for mutually orthogonal bioorthogonal reactions. ChemBioChem 22, 3254–3262 (2021).
pubmed: 34261195 doi: 10.1002/cbic.202100164
Fukui, S., Feizi, T., Galustian, C., Lawson, A. M. & Chai, W. Oligosaccharide microarrays for high-throughput detection and specificity assignments of carbohydrate-protein interactions. Nat. Biotechnol. 20, 1011–1017 (2002).
pubmed: 12219077 doi: 10.1038/nbt735
Geijtenbeek, T. B. H. & Van Kooyk, Y. Pathogens target DC-SIGN to influence their fate DC-SIGN functions as a pathogen receptor with broad specificity. APMIS 111, 698–714 (2003).
pubmed: 12974773 doi: 10.1034/j.1600-0463.2003.11107803.x
Appelmelk, B. J. et al. Cutting edge: carbohydrate profiling identifies new pathogens that interact with dendritic cell-specific ICAM-3-grabbing nonintegrin on dendritic cells. J. Immunol. 170, 1635–1639 (2003).
pubmed: 12574325 doi: 10.4049/jimmunol.170.4.1635
Gringhuis, S. I., Kaptein, T. M., Wevers, B. A., Mesman, A. W. & Geijtenbeek, T. B. Fucose-specific DC-SIGN signalling directs T helper cell type-2 responses via IKKε- and CYLD-dependent Bcl3 activation. Nat. Commun. 5, 3898 (2014).
pubmed: 24867235 doi: 10.1038/ncomms4898
Valverde, P., Martinez, J. D., Canada, F. J., Arda, A. & Jimenez-Barbero, J. Molecular recognition in C-Type Lectins: the cases of DC-SIGN, Langerin, MGL, and L-Sectin. ChemBioChem 21, 2999–3025 (2020).
pubmed: 32426893 pmcid: 7276794 doi: 10.1002/cbic.202000238
Guo, Y. et al. Structural basis for distinct ligand-binding and targeting properties of the receptors DC-SIGN and DC-SIGNR. Nat. Struct. Mol. Biol. 11, 591–598 (2004).
pubmed: 15195147 doi: 10.1038/nsmb784
Feinberg, H. et al. Structural basis for langerin recognition of diverse pathogen and mammalian glycans through a single binding site. J. Mol. Biol. 405, 1027–1039 (2011).
pubmed: 21112338 pmcid: 3065333 doi: 10.1016/j.jmb.2010.11.039
Galustian, C. et al. High and low affinity carbohydrate ligands revealed for murine SIGN‐R1 by carbohydrate array and cell binding approaches, and differing specificities for SIGN‐R3 and langerin. Int. Immunol. 16, 853–866 (2004).
pubmed: 15136555 doi: 10.1093/intimm/dxh089
Valverde, P. et al. Molecular insights into DC-SIGN binding to self-antigens: the interaction with the blood group A/B antigens. ACS Chem. Biol. 14, 1660–1671 (2019).
pubmed: 31283166 pmcid: 6646960 doi: 10.1021/acschembio.9b00458
Turnbull, W. B., Precious, B. L. & Homans, S. W. Dissecting the cholera toxin-ganglioside GM1 interaction by isothermal titration calorimetry. J. Am. Chem. Soc. 126, 1047–1054 (2004).
pubmed: 14746472 doi: 10.1021/ja0378207
Holmgren, J. Comparison of the tissue receptors for vibrio cholerae and escherichia coli enterotoxins by means of gangliosides and natural cholera toxoid. Infect. Immun. 8, 851–859 (1973).
pubmed: 4206342 pmcid: 422940 doi: 10.1128/iai.8.6.851-859.1973
Holmner, Å., Askarieh, G., Ökvist, M. & Krengel, U. Blood group antigen recognition by escherichia coli heat-labile enterotoxin. J. Mol. Biol. 371, 754–764 (2007).
pubmed: 17586525 doi: 10.1016/j.jmb.2007.05.064
Mandal, P. K. et al. Towards a structural basis for the relationship between blood group and the severity of El Tor cholera. Angew. Chem. Int. Ed. Engl. 51, 5143–5146 (2012).
pubmed: 22488789 pmcid: 3505909 doi: 10.1002/anie.201109068
Holmner, Å. et al. Novel binding site identified in a hybrid between cholera toxin and heat-labile enterotoxin: 1.9 Å Crystal. Struct. Reveals Details Struct. 12, 1655–1667 (2004).
Heggelund, J. E. et al. High-resolution crystal structures elucidate the molecular basis of cholera blood group dependence. PLOS Pathog. 12, e1005567 (2016).
pubmed: 27082955 pmcid: 4833353 doi: 10.1371/journal.ppat.1005567
Heim, J. B., Hodnik, V., Heggelund, J. E., Anderluh, G. & Krengel, U. Crystal structures of cholera toxin in complex with fucosylated receptors point to importance of secondary binding site. Sci. Rep. 9, 12243 (2019).
pubmed: 31439922 pmcid: 6706398 doi: 10.1038/s41598-019-48579-2
Wands, A. M. et al. Fucosylated molecules competitively interfere with cholera toxin binding to host cells. ACS Infect. Dis. 4, 758–770 (2018).
pubmed: 29411974 pmcid: 5948155 doi: 10.1021/acsinfecdis.7b00085
Cervin, J. et al. GM1 ganglioside-independent intoxication by Cholera toxin. PLOS Pathog. 14, e1006862 (2018).
pubmed: 29432456 pmcid: 5825173 doi: 10.1371/journal.ppat.1006862
Heggelund, J. E. et al. Specificity of escherichia coli heat-labile enterotoxin investigated by single-site mutagenesis and crystallography. Int. J. Mol. Sci. 20, 703 (2019).
pubmed: 30736336 pmcid: 6386978 doi: 10.3390/ijms20030703
Elghanian, R., Storhoff, J. J., Mucic, R. C., Letsinger, R. L. & Mirkin, C. A. Selective colorimetric detection of polynucleotides based on the distance-dependent optical properties of gold nanoparticles. Science 277, 1078–1081 (1997).
pubmed: 9262471 doi: 10.1126/science.277.5329.1078
Schofield, C. L., Haines, A. H., Field, R. A. & Russell, D. A. Silver and gold glyconanoparticles for colorimetric bioassays. Langmuir 22, 6707–6711 (2006).
pubmed: 16831017 doi: 10.1021/la060288r
Richards, S.-J. & Gibson, M. I. Optimization of the polymer coating for glycosylated gold nanoparticle biosensors to ensure stability and rapid optical readouts. ACS Macro Lett. 3, 1004–1008 (2014).
pubmed: 35610783 doi: 10.1021/mz5004882
Valverde, P. et al. Chemoenzymatic synthesis of 3-deoxy-3-fluoro-L-fucose and its enzymatic incorporation into glycoconjugates. Chem. Commun. 56, 6408–6411 (2020).
doi: 10.1039/D0CC02209H
Burkart, M. D. et al. Chemo-enzymatic synthesis of fluorinated sugar nucleotide: useful mechanistic probes for glycosyltransferases. Biorg. Med. Chem. 8, 1937–1946 (2000).
doi: 10.1016/S0968-0896(00)00139-5
Yi, W. et al. Remodeling bacterial polysaccharides by metabolic pathway engineering. Proc. Natl. Acad. Sci. USA 106, 4207–4212 (2009).
pubmed: 19251666 pmcid: 2657399 doi: 10.1073/pnas.0812432106
Cormier, C. Y. et al. Protein Structure Initiative Material Repository: an open shared public resource of structural genomics plasmids for the biological community. Nucleic Acids Res. 38, D743–D749 (2009).
pubmed: 19906724 pmcid: 2808882 doi: 10.1093/nar/gkp999
Chai, W., Stoll, M. S., Galustian, C., Lawson, A. M. & Feizi, T. in Methods in Enzymology, 362 160–195 (Academic Press, 2003).
Liu, Y. et al. The minimum information required for a glycomics experiment (MIRAGE) project: improving the standards for reporting glycan microarray-based data. Glycobiology 27, 280–284 (2017).
pubmed: 27993942
Liu, Y. et al. Neoglycolipid-based oligosaccharide microarray system: preparation of NGLs and their noncovalent immobilization on nitrocellulose-coated glass slides for microarray analyses. Methods Mol. Biol. 808, 117–136 (2012).
pubmed: 22057521 doi: 10.1007/978-1-61779-373-8_8
Bastús, N. G., Comenge, J. & Puntes, V. Kinetically controlled seeded growth synthesis of citrate-stabilized gold nanoparticles of up to 200 nm: size focusing versus ostwald ripening. Langmuir 27, 11098–11105 (2011).
pubmed: 21728302 doi: 10.1021/la201938u
Baker, A. N. et al. Lateral flow glyco-assays for the rapid and low-cost detection of lectins–polymeric linkers and particle engineering are essential for selectivity and performance. Adv. Healthc. Mater. 11, 2101784 (2022).
doi: 10.1002/adhm.202101784
Neelamegham, S. et al. Updates to the symbol nomenclature for glycans guidelines. Glycobiology 29, 620–624 (2019).
pubmed: 31184695 pmcid: 7335484 doi: 10.1093/glycob/cwz045
Harvey, D. J. et al. Proposal for a standard system for drawing structural diagrams of N- and O-linked carbohydrates and related compounds. Proteomics 9, 3796–3801 (2009).
pubmed: 19670245 doi: 10.1002/pmic.200900096

Auteurs

Kristian Hollingsworth (K)

School of Chemistry and Astbury Centre for Structural Molecular Biology, University of Leeds, Leeds, UK.

Antonio Di Maio (A)

Glycosciences Laboratory, Department of Metabolism, Digestion and Reproduction, Imperial College London, London, UK.

Sarah-Jane Richards (SJ)

Department of Chemistry, University of Warwick, Coventry, UK.
Manchester Institute of Biotechnology (MIB), Department of Chemistry, University of Manchester, Manchester, UK.

Jean-Baptiste Vendeville (JB)

School of Chemistry, University of Southampton, Highfield, Southampton, UK.

David E Wheatley (DE)

School of Chemistry, University of Southampton, Highfield, Southampton, UK.

Claire E Council (CE)

School of Chemistry, University of Southampton, Highfield, Southampton, UK.

Tessa Keenan (T)

Department of Chemistry, University of York, Heslington, York, UK.

Hélène Ledru (H)

School of Chemistry, Cantock's Close, University of Bristol, Bristol, UK.

Harriet Chidwick (H)

Department of Chemistry, University of York, Heslington, York, UK.

Kun Huang (K)

Manchester Institute of Biotechnology (MIB), Department of Chemistry, University of Manchester, Manchester, UK.

Fabio Parmeggiani (F)

Manchester Institute of Biotechnology (MIB), Department of Chemistry, University of Manchester, Manchester, UK.

Andrea Marchesi (A)

Manchester Institute of Biotechnology (MIB), Department of Chemistry, University of Manchester, Manchester, UK.

Wengang Chai (W)

Glycosciences Laboratory, Department of Metabolism, Digestion and Reproduction, Imperial College London, London, UK.

Ryan McBerney (R)

School of Chemistry and Astbury Centre for Structural Molecular Biology, University of Leeds, Leeds, UK.

Tomasz P Kamiński (TP)

School of Chemistry and Astbury Centre for Structural Molecular Biology, University of Leeds, Leeds, UK.

Matthew R Balmforth (MR)

School of Chemistry and Astbury Centre for Structural Molecular Biology, University of Leeds, Leeds, UK.

Alexandra Tamasanu (A)

School of Chemistry and Astbury Centre for Structural Molecular Biology, University of Leeds, Leeds, UK.

James D Finnigan (JD)

Prozomix Limited, Haltwhistle Industrial Estate, Haltwhistle, Northumberland, UK.

Carl Young (C)

Prozomix Limited, Haltwhistle Industrial Estate, Haltwhistle, Northumberland, UK.

Stuart L Warriner (SL)

School of Chemistry and Astbury Centre for Structural Molecular Biology, University of Leeds, Leeds, UK.

Michael E Webb (ME)

School of Chemistry and Astbury Centre for Structural Molecular Biology, University of Leeds, Leeds, UK.

Martin A Fascione (MA)

Department of Chemistry, University of York, Heslington, York, UK.

Sabine Flitsch (S)

Manchester Institute of Biotechnology (MIB), Department of Chemistry, University of Manchester, Manchester, UK.

M Carmen Galan (MC)

School of Chemistry, Cantock's Close, University of Bristol, Bristol, UK.

Ten Feizi (T)

Glycosciences Laboratory, Department of Metabolism, Digestion and Reproduction, Imperial College London, London, UK. t.feizi@imperial.ac.uk.

Matthew I Gibson (MI)

Department of Chemistry, University of Warwick, Coventry, UK. matt.gibson@manchester.ac.uk.
Manchester Institute of Biotechnology (MIB), Department of Chemistry, University of Manchester, Manchester, UK. matt.gibson@manchester.ac.uk.
Division of Biomedical Sciences, Warwick Medical School, University of Warwick, Coventry, UK. matt.gibson@manchester.ac.uk.

Yan Liu (Y)

Glycosciences Laboratory, Department of Metabolism, Digestion and Reproduction, Imperial College London, London, UK. yan.liu2@imperial.ac.uk.

W Bruce Turnbull (WB)

School of Chemistry and Astbury Centre for Structural Molecular Biology, University of Leeds, Leeds, UK. W.B.Turnbull@leeds.ac.uk.

Bruno Linclau (B)

School of Chemistry, University of Southampton, Highfield, Southampton, UK. bruno.linclau@ugent.be.
Department of Organic and Macromolecular Chemistry, Ghent University, Ghent, Belgium. bruno.linclau@ugent.be.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH